Andrew Paul Mazar insider trades

Open-market stock purchases and sales by Andrew Paul Mazar, Chief Operating Officer at Actuate Therapeutics, Inc, from SEC Form 4 filings since Aug 9, 2018.

Recent trades

DateStockTradeValue
Apr 1, 2026ACTU Actuate Therapeutics, IncBought (not open market)—

Companies traded

  • ACTU Actuate Therapeutics, Inc: other filings, last Apr 1, 2026
  • MNPR Monopar Therapeutics: other filings, last Mar 31, 2022
  • NONE Monopar Therapeutics: other filings, last Aug 9, 2018

Get free alerts when Andrew Paul Mazar files a new trade →